Literature DB >> 18272845

Caspase-3 gene deletion prolongs survival in polycystic kidney disease.

Yunxia Tao1, Iram Zafar, Jun Kim, Robert W Schrier, Charles L Edelstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18272845      PMCID： PMC2390972          DOI： 10.1681/ASN.2006121378

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  33 in total

Review 1.  Apoptotic pathways: paper wraps stone blunts scissors.

Authors:  D R Green
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

2.  Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation.

Authors:  Dean A Le; Yongqin Wu; Zhihong Huang; Kohji Matsushita; Nikolaus Plesnila; Jean C Augustinack; Bradley T Hyman; Junying Yuan; Keisuke Kuida; Richard A Flavell; Michael A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

3.  c-myc antisense oligonucleotide treatment ameliorates murine ARPKD.

Authors:  Justin L Ricker; John E Mata; Patrick L Iversen; Vincent H Gattone
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

4.  Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Vyacheslav Y Melnikov; Melinda Stanley; Didem Korular; M Scott Lucia; Robert W Schrier; Charles L Edelstein
Journal:  Kidney Int       Date:  2002-04       Impact factor: 10.612

5.  Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease.

Authors:  Vincent H Gattone; Justin L Ricker; Chad M Trambaugh; Robert M Klein
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

6.  Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease.

Authors:  Xiaoying Hou; Michal Mrug; Bradley K Yoder; Elliot J Lefkowitz; Gabriel Kremmidiotis; Peter D'Eustachio; David R Beier; Lisa M Guay-Woodford
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

7.  Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease.

Authors:  L Ostrom; M J Tang; P Gruss; G R Dressler
Journal:  Dev Biol       Date:  2000-03-15       Impact factor: 3.582

8.  Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.

Authors:  Nikolay O Bukanov; Laurie A Smith; Katherine W Klinger; Steven R Ledbetter; Oxana Ibraghimov-Beskrovnaya
Journal:  Nature       Date:  2006-11-22       Impact factor: 49.962

9.  Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice.

Authors:  Jeffrey R Leonard; Barbara J Klocke; Cleta D'Sa; Richard A Flavell; Kevin A Roth
Journal:  J Neuropathol Exp Neurol       Date:  2002-08       Impact factor: 3.685

10.  Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells.

Authors:  A Boletta; F Qian; L F Onuchic; A K Bhunia; B Phakdeekitcharoen; K Hanaoka; W Guggino; L Monaco; G G Germino
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970
View more
  23 in total

1.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD).

Authors:  Franck Belibi; Iram Zafar; Kameswaran Ravichandran; Anamarija Bauer Segvic; Alkesh Jani; Danica Galesic Ljubanovic; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

Review 3.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

4.  An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Iram Zafar; Zhibin He; R Brian Doctor; Radu Moldovan; Adam E Mullick; Charles L Edelstein
Journal:  Hum Mol Genet       Date:  2014-05-08       Impact factor: 6.150

Review 5.  Treatment strategies and clinical trial design in ADPKD.

Authors:  Vicente E Torres
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

6.  An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease.

Authors:  Kameswaran Ravichandran; Iram Zafar; Abdullah Ozkok; Charles L Edelstein
Journal:  Nephrol Dial Transplant       Date:  2014-09-19       Impact factor: 5.992

7.  Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease.

Authors:  Guangfu Jia; Michelle Kwon; Huan Ling Liang; Jordan Mortensen; Vani Nilakantan; William E Sweeney; Frank Park
Journal:  Pediatr Nephrol       Date:  2010-03-13       Impact factor: 3.714

8.  MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease.

Authors:  Ronak Lakhia; Sachin Hajarnis; Darren Williams; Karam Aboudehen; Matanel Yheskel; Chao Xing; Mark E Hatley; Vicente E Torres; Darren P Wallace; Vishal Patel
Journal:  J Am Soc Nephrol       Date:  2015-12-17       Impact factor: 10.121

9.  Disparate effects of roscovitine on renal tubular epithelial cell apoptosis and senescence: implications for autosomal dominant polycystic kidney disease.

Authors:  Jin-Young Park; See-Hyoung Park; Robert H Weiss
Journal:  Am J Nephrol       Date:  2008-12-10       Impact factor: 3.754

10.  Apoptosis and autophagy in polycystic kidney disease (PKD).

Authors:  Kristen L Nowak; Charles L Edelstein
Journal:  Cell Signal       Date:  2019-12-24       Impact factor: 4.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.